Cognipride MP 1mg/500mg/15mg Tablet
Marketer
Cognitive Life Sciences Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Cognipride MP 1mg/500mg/15mg Tablet
DiaBeteControl MP, a triple-combination tablet (1mg/500mg/15mg), effectively manages blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin utilization, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately unless the next dose is imminent; in that case, skip the missed dose. Never double the dose; overdose risks hypoglycemia. Concurrent use with other antidiabetic drugs, alcohol, or meal skipping can precipitate hypoglycemia; frequent blood glucose monitoring is crucial. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function tests will be performed before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Cognipride MP 1mg/500mg/15mg Tablet
No text was provided to rewrite.
Uses of Cognipride MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Cognipride MP 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Cognipride MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing. Consume this medication with a meal.
Common Side effects of Cognipride MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Cognipride MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Cognipride MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
How Cognipride MP 1mg/500mg/15mg Tablet works:
Cognipride MP, a triple-action antidiabetic tablet (1mg/500mg/15mg glimepiride/metformin/pioglitazone), offers enhanced blood sugar management. Its three components—a sulfonylurea (glimepiride), a biguanide (metformin), and a thiazolidinedione (pioglitazone)—act through distinct pathways. Glimepiride stimulates pancreatic insulin release to reduce blood glucose. Metformin reduces hepatic glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Pioglitazone further enhances insulin sensitivity, providing effective control when single or dual therapies prove insufficient.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Cognipride MP 1mg/500mg/15mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Cognipride MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Cognipride MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Cognipride MP 1mg/500mg/15mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The use of Cognipride MP 1mg/500mg/15mg Tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Cognipride MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Cognipride MP 1mg/500mg/15mg tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Cognipride MP 1mg/500mg/15mg Tablet :
Should you forget to take your Cognipride MP 1mg/500mg/15mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Cognipride MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently